Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2012
11/01/2012US20120277243 Pyrazolidin-3-one derivatives
11/01/2012US20120277242 Pyridin-2YL-Amino-1, 2, 4-Thiadiazole Derivatives as Glucokinase Activators for the Treatment of Diabetes Mellitus
11/01/2012US20120277241 Compounds, Formulations, and Methods for Treating or Preventing Inflammatory Skin Disorders
11/01/2012US20120277240 Substituted aminotetrahydrothiopyrans and derivatives thereof as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes
11/01/2012US20120277239 Compositions and Methods for Improving Night Vision
11/01/2012US20120277238 Pharmaceutical composition containing fused hetero-ring derivative
11/01/2012US20120277237 Novel alkynyl derivatives as modulators of metabotropic glutamate receptors
11/01/2012US20120277236 Method for inhibiting mmp-9 dimerization
11/01/2012US20120277235 Compositions For Topical Application Having Androgenic Actions
11/01/2012US20120277234 1,2,4-oxadiazole benzoic acids
11/01/2012US20120277233 Pyridyl-Triazine Inhibitors of Hedgehog Signaling
11/01/2012US20120277232 Pyridine and Pyrazine Derivative for the Treatment of CF
11/01/2012US20120277231 Quinolinyloxyphenylsulfonamides
11/01/2012US20120277230 Compounds useful for treating cancer
11/01/2012US20120277229 Substituted 3-(1h-benzo[d]imidazol-2-yl)-1h-indazole analogs as inhibitors of the pdk1 kinase
11/01/2012US20120277228 Novel Azaheterocyclic Compounds
11/01/2012US20120277227 Benzimidazole inhibitors of leukotriene production
11/01/2012US20120277226 Benzimidazole inhibitors of leukotriene production
11/01/2012US20120277225 Inhibitors of bruton's tyrosine kinase
11/01/2012US20120277224 Heterocyclic compounds for the inhibition of pask
11/01/2012US20120277223 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
11/01/2012US20120277222 Treating various disorders using trkb agonists
11/01/2012US20120277221 Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseases
11/01/2012US20120277220 5 OXO-5,8-DIHYDROPYRIDO[2,3-d]PYRIMIDINE DERIVATIVES AS CAMKII KINASE INHIBITORS FOR TREATING CARDIOVASCULAR DISEASES
11/01/2012US20120277219 Novel pyridopyrazine derivatives, process of manufacturing and uses thereof
11/01/2012US20120277218 Methods and pharmaceutical compositions for treating down syndrome
11/01/2012US20120277217 Imidazole Derivatives as IDO Inhibitors
11/01/2012US20120277216 1,2-dihydro-2-oxoquinoline compounds as 5-ht4 receptor ligands
11/01/2012US20120277215 Organic Compounds
11/01/2012US20120277214 Tricyclopyrazole derivatives
11/01/2012US20120277213 Ethynyl compounds
11/01/2012US20120277212 Novel Oxime Derivatives and Their Use As Allosteric Modulators of Metabotropic Glutamate Receptors
11/01/2012US20120277211 Methods and compositions for the treatment of psychotic disorders through the identification of the sult4a1-1 haplotype
11/01/2012US20120277210 Solid dispersions containing an apoptosis-inducing agent
11/01/2012US20120277209 Pyrazine compounds as phosphodiesterase 10 inhibitors
11/01/2012US20120277208 Benzamide compound
11/01/2012US20120277207 Novel heterocyclic acrylamides and their use as pharmaceuticals
11/01/2012US20120277206 Reverse transcriptase inhibitors
11/01/2012US20120277205 Derivatives of n-[(1h-pyrazol-1-yl)aryl]-1h-indole or 1h-indazole-3-carboxamide, preparation thereof and applications thereof in therapeutics
11/01/2012US20120277204 Pyridazinone compounds
11/01/2012US20120277203 Androstenediol as an indicator for assessing estrogenicity
11/01/2012US20120277202 Controlled release delivery system for nasal applications and methods of treatment
11/01/2012US20120277201 Use of hydroxyprogesterone derivatives for enhancing health and physical performance
11/01/2012US20120277200 Use of testosterone and a 5-ht1a agonist in the treatment of sexual dysfunction
11/01/2012US20120277199 Modulation of Gel Temperature of Poloxamer-Containing Formulations
11/01/2012US20120277198 Polyhydroxylated bile acids for treatment of biliary disorders
11/01/2012US20120277197 Tigecycline formulations
11/01/2012US20120277196 Natural marine source phospholipids comprising polyunsaturated fatty acids and their applications
11/01/2012US20120277195 Permeation enhancers for topical formulations
11/01/2012US20120277194 Aminopropanol derivatives
11/01/2012US20120277193 Synergistic Combination Therapy
11/01/2012US20120277192 Aminopyrimidines as syk inhibitors
11/01/2012US20120277191 Forms of cidofovir
11/01/2012US20120277190 Prodrugs of compounds that inhibit trpv1 receptor
11/01/2012US20120277189 Water-soluble benzoazepine compound and its pharmaceutical composition
11/01/2012US20120277188 Water-soluble benzoazepine compound and its pharmaceutical composition
11/01/2012US20120277187 Agent for Preventing Infection
11/01/2012US20120277186 Tricyclic Derivatives and Their Pharmaceutical Use and Compositions
11/01/2012US20120277184 Blockers of pore-forming virulence factors and their use as anti-infectives
11/01/2012US20120277183 Phosphate-binding chitosan and uses thereof
11/01/2012US20120277182 Anoectochilus spp. polysaccharide extracts for stimulating growth of advantageous bacteria, stimulating release of granulocyte colony-stimulating factor, modulating t helper cell type i, and/or modulating t helper cell type ii and uses of the same
11/01/2012US20120277181 Lactulose for bowel evacuation
11/01/2012US20120277180 Cofactors and Methods for Use for Individuals
11/01/2012US20120277179 Edible Energy Composition
11/01/2012US20120277178 Compositions and methods for treating fragile x premutation rvgg repeats-mediated toxicity
11/01/2012US20120277177 Crystalline phases of 5,6-dichloro-2-(isopropylamino)-1-beta-ribofuranosyl-1h-benzimidazole
11/01/2012US20120277176 Protein Arginine Deiminase Inhibitors as Novel Therapeutics for Rheumatoid Arthritis and Cancer
11/01/2012US20120277175 Pharmaceutical combinations, pharmaceutical compositions, medicament and method for the treatment of animals
11/01/2012US20120277174 New macrolides and their use
11/01/2012US20120277173 Stabilized anthocyanin compositions
11/01/2012US20120277172 Carbohydrate-lipid constructs and their use in preventing or treating viral infection
11/01/2012US20120277171 Warmi®, natural alternative for the treatment of menopause
11/01/2012US20120277170 Nutritive compositions and methods of using same
11/01/2012US20120277169 Nyasol and analogs thereof for the treatment of estrogen receptor beta-mediated diseases
11/01/2012US20120277156 Inhibition of pathological bone formation
11/01/2012US20120277150 Novel 3-hydroxyisothiazole 1-oxide derivative
11/01/2012US20120277149 Pharmaceutical combinations for the treatment of metabolic disorders
11/01/2012US20120277144 Novel compounds for modulating neovascularisation and methods of treatment using these compounds
11/01/2012US20120277142 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same
11/01/2012US20120276221 Biodisintegrable medical devices
11/01/2012US20120276214 Infant nutrition with protease inhibitor
11/01/2012US20120276212 Composition comprising plant and/or fish oils and non-oxidizable fatty acid entities
11/01/2012US20120276210 Shampoo Compositions with Increased Deposition of Polyacrylate Microcapsules
11/01/2012US20120276209 Nucleic acid-containing lipid particles and related methods
11/01/2012US20120276208 Acute cognitive and mood effects of plant polysaccharides in adult human subjects
11/01/2012US20120276207 Methods for preparation of lipid-encapsulated therapeutic agents
11/01/2012US20120276206 Method for manufacturing acid pellets
11/01/2012US20120276204 Bone Growth Compositions and Methods
11/01/2012US20120276200 Formulations of quinolinones
11/01/2012US20120276199 Taste masked pharmaceutical formulations
11/01/2012US20120276198 Pharmaceutical composition for treating parkinson's disease and preparation method thereof
11/01/2012US20120276197 Dosage Form to Increase Prasterone Bioavailability
11/01/2012US20120276196 Pharmaceutical Compositions of a Neuroactive Steroid and Methods of Use Thereof
11/01/2012US20120276195 Indole Alkaloid Derivatives Having Opioid Receptor Agonistic Effect, And Therapeutic Compositions And Methods Relating To Same
11/01/2012US20120276194 Pharmaceutical composition based on micronized progesterone, preparation method and uses thereof
11/01/2012US20120276192 Compositions and methods for sirna inhibition of icam-1
11/01/2012US20120276191 Treatment and Diagnosis of Macrophage Mediated Disease
11/01/2012US20120276189 Therapeutic Treatment of Dermatologic Skin Disorders
11/01/2012US20120276186 Sustained release latanoprost implant
11/01/2012US20120276184 Solvent cast film sustained release latanoprost implant
1 ... 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 994 ... 7860